In this episode we discuss the importance of the Community Advisory Committee (CAC) at The Canadian Biomarker Integration Network in Depression (CAN-BIND. We also interview 2 of our CAC members (Madeline and Michael) on their personal experiences as well as what they enjoy doing as the CAC.

READ TRANSCRIPT HERE: https://www.canbind.ca/videos/podcasts/

Podcast was recorded in June 2020 

Hosted by Dr. Wegdan Rashad
Guests: Dr. Sagar Parikh, Madeline Surman and Michael Lloyd
Audio editing: Serhii Artiukh
Music: Make your dreams a reality by scottholmesmusic.com

See you in the next episode,

The CAN-BIND team
canbind.ca

Nothing About Us Without Us- Community Involvement in Research

Over the past decade, CAN-BIND has led the charge in scientific exploration, pushing boundaries, challenging stigma, and conducting groundbreaking research in collaboration with patients and families.

In this special episode, join our host, Dr. Fabiano Gomes, and CAN-BIND Program Manager, Dr. Susan Rotzinger, as they take you on an exciting journey through the last 10 years of CAN-BIND's pioneering work in depression research.

Host: Dr. Fabiano Gomes
Guest: Dr. Susan Rotzinger
Producer: Dr. Nirushi Kuhathasan
Audio editors: Christina Macaluso & Dr. Nirushi Kuhathasan
Music: Teamwork by scottholmesmusic.com

A Decade of Unravelling Mood Disorder Mysteries: The CAN-BIND Research Journey

The rise of artificial intelligence is redefining healthcare, shaping both how mental health is studied and how care is delivered.

In part two of this two-part conversation, host Dr. Sagar Parikh returns with Dr. Frank Rudzicz, Associate Professor in the Faculty of Computer Science at Dalhousie University and Canada CIFAR Chair in Artificial Intelligence. They explore how AI is being applied within the CAN-BIND program, its impact on research and clinical decision-making, and the ethical questions that arise when integrating AI into mental health care. Together, they reflect on how to balance innovation with the responsible use of this powerful technology.

Listen in to discover how AI is driving innovation in mental health care while thoughtfully addressing the ethical challenges it brings.

Host: Dr. Sagar Parikh
Guest: Dr. Frank Rudzicz
Producer: Dr. Nirushi Kuhathasan
Audio Editor: Anastasiia Marmyzova
Music: Teamwork by scottholmesmusic.com

Artificial Intelligence and Mental Health: The Future of Care? [Part 2]

Listen to Dr. Gregor Hasler's interview on Neuroplasticity, depression and psychedelics research. The Canadian Biomarker Integration Network in Depression (CAN-BIND) hosted Dr. Hasler in February 2020 in Toronto, Canada.

Interviewees: Dr. Gregor Hasler and Dr. Sidney Kennedy
Hosted by Dr. Wegdan Rashad
Audio editing: Damien Murphy
Music: Make your dreams a reality by scottholmesmusic.com

See you in the next episode,

The CAN-BIND team
canbind.ca

CANBIND Podcast

Dr. Gregor Hasler Interview: Neuroplasticity, Depression and Psychedelics

In this episode we discuss an exciting study by The Canadian Biomarker Integration Network in Depression (CAN-BIND), that aims to compare ketamine and electroconvulsive therapy for the treatment of resistant depression. 

Our guests are, Sophie, a patient participant in this study and Dr. Jennifer  Phillips, Associate Scientist at the Mood Disorders Research Unit at the Royal Institute of Mental Health Research, University of Ottawa.

READ TRANSCRIPT HERE: https://www.canbind.ca/episode-02-ketamine-vs-ect-for-resistant-depression/

Podcast was recorded 25 Feb 2020 and 20 April 2020.

Hosted by Dr. Wegdan Rashad
Audio editing: Damien Murphy
Music: Make your dreams a reality by scottholmesmusic.com

See you in the next episode,

The CAN-BIND team
canbind.ca

CAN-BIND Podcast

Ketamine Vs ECT in Resistant Depression: CAN-BIND Study

A series of groundbreaking studies in depression aimed at shortening the path from diagnosis, to getting the right treatment.